Dr. Martin Schulz currently serves as Global Medical Affairs Team Lead for Sickle Cell Disease at Pfizer Rare Disease. He has 15+ years of experience in the biopharmaceutical industry. This work has mainly focused on non-malignant hematologic conditions with a most recent focus on sickle cell disease. Martin is a registered pharmacist, holds a PhD in Pharmaceutics from Freie Universität Berlin and has published numerous peer-reviewed articles.
